Specialty Imaging: HRCT of the Lung

Specialty Imaging: HRCT of the Lung 3e delivers a powerful solution to make lung diseases diagnoses easier for radiologists, including general radiologists, cardiothoracic radiologists, pulmonologists, and rheumatologists. High-resolution computer tomography has long been identified as delivering enhanced resolution and is most commonly used for lung disease diagnoses. Lung disease diagnoses are quite complex though, and have an anatomical and pathological component in addition to the radiology perspective. In over 130 chapters, this book’s organization provides the path to successful diagnosis with chapter titles that include the name of an entity as in chapters that use specific imaging patterns or even pathologic patterns to help determine the correct diagnosis. While the radiologist will often not know which specific pathologies are involved when reading a case, the content in SI: HRCT of the Lung 3e offers additional direction to determine the dx based on morphologic features, distribution of abnormalities, and/or histologic patterns. Since this book’s 2e published in 2017, there have significant changes and updates to identified diseases, including new morphological patterns for pulmonary fibrosis, a new classification for hypersensitivity pneumonia that has been endorsed globally by the ATS/ERS/JRS/ALAT federations. In addition, there are new chapters in place for post-COVID-19 findings, EVALI (lung disease caused by e-cigarettes and vaping), and RSV, along with updated images and new literature references throughout.

New to this edition 
 

• Updated contents throughout includes new images and the most current literature references for the 3e. In additional, new content is added to existing chapters and completely new chapters reflect updates in • New morphologic patterns for pulmonary fibrosis • New classification for hypersensitivity pneumonia • AI use for diagnosis of interstitial lung diseases • Post-COVID-19 findings • Respiratory Syncytial Virus (RSV) • New chapter on EVALI (e-cigarette or vaping use-associated lung injury)

Key Features 
 

• Updated content in existing chapters to reflect newest disease diagnoses, including for morphologic patterns for pulmonary fibrosis • Details on new classification for hypersensitivity pneumonia • Focused content on AI use for diagnosis of interstitial lung diseases • New chapters on more prevalent diagnoses include post-COVID-19 findings, Respiratory Syncytial Virus (RSV) and EVALI (e-cigarette or vaping use-associated lung injury)

By Santiago Martínez-Jiménez, MD, Department of Radiology, Saint Luke's Hospital of Kansas City, Professor of Radiology, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri; Melissa L. Rosado-de-Christenson, MD, FACR, FAAWR, Melissa L. Rosado-de-Christenson, MD, FACR, FAAWR, Attending Radiologist, Division of Cardiothoracic Imaging, Department of Medical Imaging, Banner – University Medical Group Tucson, Professor of Medical Imaging, University of Arizona College of Medicine – Tucson, Tucson, Arizona and Sherief Garrana, MD, Clinical Assistant Professor of Radiology, Division of Thoracic Imaging, Department of Radiology, NYU Langone Health, New York, New York